BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

BIO

Bio-rad Laboratories, Inc.
NYSE · Laboratory analytical instruments (SIC 3826) · FY ends 31 Dec

Revenue, quarterly

$651M−0.1% year on year
$750M$500M$250M$0
Q3 ’21Q4 ’22Q1 ’24Q1 ’25Q2 ’26
Company filings · 10-Q filed 4 Aug 2026 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

51.9%−0.9 pp year on year
58%56%54%52%50%
Q3 ’21Q4 ’22Q1 ’24Q1 ’25Q2 ’26
Company filings · 10-Q filed 4 Aug 2026 · TTM = last four quartersvpside.com

Cash and cash equivalents, quarter-end

$517M+40.0% year on year
$1B$500M$0
Q3 ’21Q4 ’22Q1 ’24Q1 ’25Q2 ’26
Company filings · 10-Q filed 4 Aug 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

$353M−4.8% year on year
$750M$500M$250M$0
Q3 ’21Q4 ’22Q1 ’24Q1 ’25Q2 ’26
Company filings · 10-Q filed 4 Aug 2026 · TTM = last four quartersvpside.com
Chart 05 is empty
Chart 06 is empty